About this Journal Submit a Manuscript Table of Contents
Stroke Research and Treatment
Volume 2011 (2011), Article ID 670138, 9 pages
http://dx.doi.org/10.4061/2011/670138
Review Article

Role of Investigating Thrombophilic Disorders in Young Stroke

Division of Neurology, Department of Medicine, National University Hospital, 1E, Kent Ridge Road, Singapore 119228

Received 15 September 2010; Revised 22 December 2010; Accepted 5 January 2011

Academic Editor: Halvor Naess

Copyright © 2011 Kay W. P. Ng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Varona, J. M. Guerra, F. Bermejo, J. A. Molina, and A. Gomez de la Cámara, “Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term,” European Neurology, vol. 57, no. 4, pp. 212–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Scopus
  3. S. J. Kittner, B. J. Stern, M. Wozniak et al., “Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study,” Neurology, vol. 50, no. 4, pp. 890–894, 1998. View at Scopus
  4. J. Putaala, A. J. Metso, T. M. Metso et al., “Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke the Helsinki young stroke registry,” Stroke, vol. 40, no. 4, pp. 1195–1203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. E. S. Roach, M. R. Golomb, R. Adams et al., “Management of stroke in infants and children: a scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young,” Stroke, vol. 39, no. 9, pp. 2644–2691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. D. Walker, M. Greaves, and F. E. Preston, “Investigation and management of heritable thrombophilia,” British Journal of Haematology, vol. 114, no. 3, pp. 512–528, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. G. J. Hankey, J. W. Eikelboom, F. M. van Bockxmeer, E. Lofthouse, N. Staples, and R. I. Baker, “Inherited thrombophilia in ischemic stroke and its pathogenic subtypes,” Stroke, vol. 32, no. 8, pp. 1793–1799, 2001. View at Scopus
  8. I. Martinelli, P. M. Mannucci, V. de Stefano et al., “Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families,” Blood, vol. 92, no. 7, pp. 2353–2358, 1998. View at Scopus
  9. P. M. Ridker, C. H. Hennekens, K. Lindpaintner, M. J. Stampfer, P. R. Eisenberg, and J. P. Miletich, “Mutation in the gene coding for coagulation factor v and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men,” New England Journal of Medicine, vol. 332, no. 14, pp. 912–917, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Nedeltchev, T. A. der Maur, D. Georgiadis et al., “Ischaemic stroke in young adults: predictors of outcome and recurrence,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 2, pp. 191–195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. F. R. Rosendaal, C. J. M. Doggen, A. Zivelin et al., “Geographic distribution of the 20210 G to A prothrombin variant,” Thrombosis and Haemostasis, vol. 79, no. 4, pp. 706–708, 1998. View at Scopus
  12. V. de Stefano, P. Chiusolo, K. Paciaroni et al., “Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients,” Blood, vol. 91, no. 10, pp. 3562–3565, 1998. View at Scopus
  13. K. H. Reuner, A. Ruf, A. Grau et al., “Prothrombin gene G20210–>A transition is a risk factor for cerebral venous thrombosis,” Stroke, vol. 29, no. 9, pp. 1765–1769, 1998. View at Scopus
  14. P. Jerrard-Dunne, A. Evans, R. McGovern et al., “Ethnic differences in markers of thrombophilia implications for the investigation of ischemic stroke in multiethnic populations: the south London ethnicity and stroke study,” Stroke, vol. 34, no. 8, pp. 1821–1826, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Mayer, R. L. Sacco, A. Hurlet-Jensen, T. Shi, and J. P. Mohr, “Free protein S deficiency in acute ischemic stroke: a case-control study,” Stroke, vol. 24, no. 2, pp. 224–227, 1993. View at Scopus
  16. R. C. Tait, I. D. Walker, P. H. Reitsma et al., “Prevalence of protein C deficiency in the healthy population,” Thrombosis and Haemostasis, vol. 73, no. 1, pp. 87–93, 1995. View at Scopus
  17. J. Kohler, J. Kasper, I. Witt, and G. M. von Reutern, “Ischemic stroke due to protein C deficiency,” Stroke, vol. 21, no. 7, pp. 1077–1080, 1990. View at Scopus
  18. X. Douay, C. Lucas, C. Caron, J. Goudemand, and D. Leys, “Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke,” Acta Neurologica Scandinavica, vol. 98, no. 2, pp. 124–127, 1998. View at Scopus
  19. I. Y. Tiong, M. L. Alkotob, and S. Ghaffari, “Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke,” Heart, vol. 89, no. 2, p. E7, 2003. View at Scopus
  20. M. Camerlingo, G. Finazzi, L. Casto, C. Laffranchi, T. Barbui, and A. Mamoli, “Inherited protein C deficiency and nonhemorrhagic arterial stroke in young adults,” Neurology, vol. 41, no. 9, pp. 1371–1373, 1991. View at Scopus
  21. A. Girolami, P. Simioni, A. R. Lazzaro, and I. Cordiano, “Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study,” Thrombosis and Haemostasis, vol. 61, no. 1, pp. 144–147, 1989. View at Scopus
  22. R. C. Tait, I. D. Walker, D. J. Perry et al., “Prevalence of antithrombin deficiency in the healthy population,” British Journal of Haematology, vol. 87, no. 1, pp. 106–112, 1994. View at Scopus
  23. J. Mateo, A. Oliver, M. Borrell, N. Sala, and J. Fontcuberta, “Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism—results of the Spanish multicentric study on thrombophilia (EMET-Study),” Thrombosis and Haemostasis, vol. 77, no. 3, pp. 444–451, 1997. View at Scopus
  24. D. A. Lane, P. M. Mannucci, K. A. Bauer et al., “Inherited thrombophilia: part 1,” Thrombosis and Haemostasis, vol. 76, no. 5, pp. 651–662, 1996.
  25. J. W. Eikelboom, G. J. Hankey, S. S. Anand, E. Lofthouse, N. Staples, and R. I. Baker, “Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke,” Stroke, vol. 31, no. 5, pp. 1069–1075, 2000.
  26. J. P. Casas, L. E. Bautista, L. Smeeth, P. Sharma, and A. D. Hingorani, “Homocysteine and stroke: evidence on a causal link from mendelian randomisation,” Lancet, vol. 365, no. 9455, pp. 224–232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. S. Wald, N. J. Wald, J. K. Morris, and M. Law, “Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence,” British Medical Journal, vol. 333, no. 7578, pp. 1114–1117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. Homocysteine Lowering Trialists’ Collaboration, “Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials,” British Medical Journal, vol. 316, no. 7135, pp. 894–898, 1998. View at Scopus
  29. The VITATOPS Trial Study Group, “B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial,” Lancet Neurology, vol. 9, no. 9, pp. 855–865, 2010. View at Publisher · View at Google Scholar
  30. R. T. Urbanus, B. Siegerink, M. Roest, F. R. Rosendaal, P. G. de Groot, and A. Algra, “Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study,” Lancet Neurology, vol. 8, no. 11, pp. 998–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Galli, D. Luciani, G. Bertolini, and T. Barbui, “Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature,” Blood, vol. 101, no. 5, pp. 1827–1832, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Lim, M. A. Crowther, and J. W. Eikelboom, “Management of antiphospholipid antibody syndrome: a systematic review,” Journal of the American Medical Association, vol. 295, no. 9, pp. 1050–1057, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. E. N. Harris, “Special report. The second international anti-cardiolipin standardization workshop/the Kingston anti-phospholipid antibody study (KAPS) group,” American Journal of Clinical Pathology, vol. 94, no. 4, pp. 476–484, 1990. View at Scopus
  35. R. Cervera, J. C. Piette, J. Font et al., “Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients,” Arthritis and Rheumatism, vol. 46, no. 4, pp. 1019–1027, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. R. L. Brey, C. L. Stallworth, D. L. McGlasson et al., “Antiphospholipid antibodies and stroke in young women,” Stroke, vol. 33, no. 10, pp. 2396–2400, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. R. Levine, R. L. Brey, B. C. Tilley, et al., “Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke,” Journal of the American Medical Association, vol. 291, no. 5, pp. 576–584, 2004. View at Publisher · View at Google Scholar
  38. J. P. Mohr, J. L. P. Thompson, R. M. Lazar et al., “A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke,” New England Journal of Medicine, vol. 345, no. 20, pp. 1444–1451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Lim, “Antiphospholipid antibody syndrome,” Hematology, pp. 233–239, 2009. View at Scopus
  40. T. E. Warkentin, “Clinical picture of heparin-induced thrombocytopenia,” in Heparin-Induced Thrombocytopenia, T. E. Warkentin and A. des Greinacher, Eds., pp. 43–86, Marcel Dekker, New York, NY, USA, 2nd edition, 2001.
  41. S. Erqou, S. Kaptoge, P. L. Perry et al., “Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality,” Journal of the American Medical Association, vol. 302, no. 4, pp. 412–423, 2009. View at Publisher · View at Google Scholar
  42. J. D. Spence, “The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions,” Canadian Journal of Cardiology, vol. 26, pp. 37A–40A, 2010. View at Scopus
  43. S. R. Levine, “Hypercoagulable states and stroke: a selective review,” CNS Spectrums, vol. 10, no. 7, pp. 567–578, 2005. View at Scopus
  44. A. Pezzini, E. del Zotto, M. Magoni et al., “Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale,” Stroke, vol. 34, no. 1, pp. 28–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. V. K. Sharma, H. L. Teoh, and B. P. L. Chan, “Patent foramen ovale and prothrombotic markers in young stroke patients,” Blood Coagulation and Fibrinolysis, vol. 19, no. 4, pp. 326–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Pezzini, M. Grassi, E. del Zotto et al., “Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults,” Stroke, vol. 36, no. 3, pp. 533–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. C. Slooter, F. R. Rosendaal, B. C. Tanis, J. M. Kemmeren, Y. van der Graaf, and A. Algra, “Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke,” Journal of Thrombosis and Haemostasis, vol. 3, no. 6, pp. 1213–1217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Martinelli, T. Battaglioli, I. Burgo, S. Di Domenico, and P. M. Mannucci, “Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke,” Haematologica, vol. 91, no. 6, pp. 844–847, 2006. View at Scopus
  49. C. Bushnell, Z. Siddiqi, J. C. Morgenlander, and L. B. Goldstein, “Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke,” Neurology, vol. 56, no. 5, pp. 624–627, 2001. View at Scopus
  50. G. J. Hankey and J. W. Eikelboom, “Routine thrombophilia testing in stroke patients is unjustified,” Stroke, vol. 34, no. 8, pp. 1826–1827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. D. M. Cohn, F. Vansenne, A. A. Kaptein, C. A. J. M. de Borgie, and S. Middeldorp, “The psychological impact of testing for thrombophilia: a systematic review,” Journal of Thrombosis and Haemostasis, vol. 6, no. 7, pp. 1099–1104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. S. J. M. Homsma, R. Huijgen, S. Middeldorp, E. J. G. Sijbrands, and J. J. P. Kastelein, “Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance,” European Journal of Human Genetics, vol. 16, no. 1, pp. 14–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. D. M. Cohn, S. Roshani, and S. Middeldorp, “Thrombophilia and venous thromboembolism: implications for testing,” Seminars in Thrombosis and Hemostasis, vol. 33, no. 6, pp. 573–581, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Tripodi and P. M. Mannucci, “Laboratory investigation of thrombophilia,” Clinical Chemistry, vol. 47, no. 9, pp. 1597–1606, 2001. View at Scopus
  55. C. D. Bushnell and L. B. Goldstein, “Diagnostic testing for coagulopathies in patients with ischemic stroke,” Stroke, vol. 31, no. 12, pp. 3067–3078, 2000. View at Scopus
  56. J. G. Morris, S. Singh, and M. Fisher, “Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?” Stroke, vol. 41, no. 12, pp. 2985–2990, 2010. View at Publisher · View at Google Scholar
  57. V. Boulyjenkov, “Inherited thrombophilia: memorandum from a joint WHO/international society on Thrombosis and Haemostasis meeting,” Bulletin of the World Health Organization, vol. 75, no. 3, pp. 177–189, 1997. View at Scopus
  58. F. J. Carod-Artal, S. V. Nunes, D. Portugal, T. V. Fernandes Silva, and A. P. Vargas, “Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital,” Stroke, vol. 36, no. 9, pp. 2012–2014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Gacs, A. J. Fox, H. J. M. Barnett, and F. Vinuela, “Occurrence and mechanisms of occlusion of the anterior cerebral artery,” Stroke, vol. 14, no. 6, pp. 952–959, 1983. View at Scopus
  60. P. K. Loh and V. K. Sharma, “Atherosclerosis in congenital azygous solitary A2 anterior cerebral artery with simultaneous bifrontal infarctions,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 2, article 203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. S. R. Levine, M. J. Deegan, N. Futrell, and K. M. A. Welch, “Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases,” Neurology, vol. 40, no. 8, pp. 1181–1189, 1990. View at Scopus
  62. M. Amiri, J. W. Schmidley, L. M. Fink, and S. M. Nazarian, “Is testing for inherited coagulation inhibitor deficiencies in young stroke patients worthwhile?” Clinical Neurology and Neurosurgery, vol. 102, no. 4, pp. 219–222, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. M. L. Brigden, “The hypercoagulable state: who, how, and when to test and treat,” Postgraduate Medicine, vol. 101, no. 5, pp. 249–263, 1997. View at Scopus
  64. M. D. Lockshin, L. R. Sammaritano, and S. Schwartzman, “Validation of the Sapporo criteria for antiphospholipid syndrome,” Arthritis and Rheumatism, vol. 43, no. 2, pp. 440–443, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. M. C. Fields and S. R. Levine, “Thrombophilias and stroke: diagnosis, treatment, and prognosis,” Journal of Thrombosis and Thrombolysis, vol. 20, no. 2, pp. 113–126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Duran, B. Biner, M. Demir, C. Celtik, and S. Karasalihoğlu, “Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke,” Clinical and Applied Thrombosis/Hemostasis, vol. 11, no. 1, pp. 83–88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Angelini, A. Ravelli, R. Caporali, and A. Martini, “Antiphospholipid antibodies in children with idiopathic cerebral ischaemia,” Lancet, vol. 344, no. 8931, article 1232, 1994. View at Scopus
  68. R. G. Hart and V. T. Miller, “Cerebral infarction in young adults: a practical approach,” Stroke, vol. 14, no. 1, pp. 110–114, 1983. View at Scopus
  69. C. Amlie-Lefond, G. Sébire, and H. J. Fullerton, “Recent developments in childhood arterial ischaemic stroke,” Lancet Neurology, vol. 7, no. 5, pp. 425–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Green, “Thrombophilia and stroke,” Topics in Stroke Rehabilitation, vol. 10, no. 3, pp. 21–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. B. R. Brenner, U. Nowak-Göttl, A. Kosch, M. Manco-Johnson, and M. Laposata, “Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children,” Archives of Pathology and Laboratory Medicine, vol. 126, no. 11, pp. 1296–1303, 2002. View at Scopus
  72. V. de Stefano, E. Rossi, K. Paciaroni, and G. Leone, “Screening for inherited thrombophilia: indications and therapeutic implications,” Haematologica, vol. 87, no. 10, pp. 1095–1108, 2002. View at Scopus
  73. M. Greaves, H. Cohen, S. J. Machin, and I. Mackie, “Guidelines on the investigation and management of the antiphospholipid syndrome,” British Journal of Haematology, vol. 109, no. 4, pp. 704–715, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. B. L. Cucchiara, “Evaluation and management of stroke,” Hematology, pp. 293–301, 2009. View at Scopus
  75. R. Weber, M. Goertler, J. Benemann, H. C. Diener, and C. Weimar, “Prognosis after cryptogenic cerebral ischemia in patients with coagulopathies,” Cerebrovascular Diseases, vol. 28, no. 6, pp. 611–617, 2009. View at Publisher · View at Google Scholar
  76. J. R. Payne and B. Coull, “Antithrombotic therapy for stroke in young adults,” Journal of Thrombosis and Thrombolysis, vol. 20, no. 2, pp. 127–132, 2005. View at Publisher · View at Google Scholar · View at Scopus